Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 3/20 | 0.45 |
| ▸ | REN | P00797 | 2/20 | 0.40 |
| ▸ | ACE | P12821 | 1/20 | 0.40 |
| ▸ | CMA1 | P23946 | 2/20 | 0.40 |
| ▸ | XIAP | P98170 | 1/20 | 0.40 |
| ▸ | ITGB1 | P05556 | 2/20 | 0.38 |
| ▸ | ITGA5 | P08648 | 1/20 | 0.38 |
| ▸ | NMUR2 | Q9GZQ4 | 2/20 | 0.38 |
| ▸ | NMUR1 | Q9HB89 | 2/20 | 0.38 |
| ▸ | F2 | P00734 | 2/20 | 0.38 |
| ▸ | ITGA4 | P13612 | 1/20 | 0.37 |
| ▸ | F10 | P00742 | 1/20 | 0.37 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30353032 | 0.93 | F2 (0.42) | OPRM1NMUR2NMUR1F2F10 | |
| SCHEMBL29591889 | 0.91 | OPRM1 (0.46) | OPRM1NMUR2NMUR1F2 | |
| SCHEMBL29679979 | 0.89 | CAPN1 (0.48) | XIAPNMUR2NMUR1 | |
| SCHEMBL29660884 | 0.87 | CAPN1 (0.47) | OPRM1RENACECMA1XIAP | |
| SCHEMBL30315472 | 0.85 | XIAP (0.52) | OPRM1RENACEXIAP | |
| SCHEMBL30315374 | 0.85 | REN (0.51) | RENACEF2 | |
| SCHEMBL28313317 | 0.85 | ACE (0.48) | RENACEF2 | |
| SCHEMBL28313314 | 0.85 | ACE (0.48) | RENACEF2 | |
| SCHEMBL30264441 | 0.85 | OPRM1 (0.42) | OPRM1RENACECMA1XIAP | |
| SCHEMBL29641641 | 0.84 | OPRM1 (0.51) | OPRM1RENACECMA1XIAP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230321218-A1 | SARS-COV2 CORONAVIRUS RECONSTITUTED RBM AND USES THEREOF | RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) | 2023-10-12 | — | — | US | disclosed |
| US-11746127-B2 | Coronaviruses epitope-based vaccines | RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) | 2023-09-05 | — | — | US | disclosed |
| EP-4132949-A1 | SARS-COV2 CORONAVIRUS RECONSTITUTED RBM AND USES THEREOF | Ramot at Tel-Aviv University Ltd. (IL) | 2023-02-15 | — | — | EP | disclosed |